LONDON, Nov 25 (Reuters) – A costly blood cancer pill sold
in Europe by Johnson & Johnson will be made routinely
available to certain patients in Britain with chronic
lymphocytic leukaemia, after the…
The post Costly leukaemia pill wins UK green light after price cut appeared first on NASDAQ.